Alcyone Lifesciences Appoints Michael Rogawski, International Expert In Treatment Of Seizures And Epilepsy To Its Clinical And Scientific Advisory Board
Alcyone Lifesciences, Inc., a privately-held medical device company developing products for the treatment of difficult neuropathological conditions, announced the appointment of Michael Rogawski, MD., PhD., of University of California, Davis to its clinical and scientific advisory board.
“Throughout his career, Dr. Rogawski has been in the forefront of bringing novel and effective treatment for hard to treat seizures and epilepsy,” said PJ Anand, Founder and Chief Executive Officer, Alcyone Lifesciences. “His research continues to drive significant advancement in the field and we look forward to his contribution to Alcyone.”
Help employers find you! Check out all the jobs and post your resume.
“Throughout his career, Dr. Rogawski has been in the forefront of bringing novel and effective treatment for hard to treat seizures and epilepsy,” said PJ Anand, Founder and Chief Executive Officer, Alcyone Lifesciences. “His research continues to drive significant advancement in the field and we look forward to his contribution to Alcyone.”
Help employers find you! Check out all the jobs and post your resume.